Delivery Order SPE2DB20D3103-SPE2DB25FM4N2

Award Date 1/24/25
Potential Completion Date 1/27/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,094.91 firm-fixed-price delivery order contract is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product. The contract has an ultimate completion date of May 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,871.68 firm fixed-price delivery order is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML medical products. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,068.33 firm fixed-price delivery order is for the supply of 4,568,037,376 units of the 60 mg/3 mL DUROLANE syringe. The contract has an ultimate completion date of April 28, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp (AmerisourceBergen), a major pharmaceutical distributor, provides for the delivery of DUROLANE 60MG/3ML 1S medical supplies. The $58,615.48 Firm Fixed Price Delivery Order was awarded on October 18, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract has an ultimate completion date of November 15, 2024 and was not set aside for any specific business type....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,930.24 firm fixed-price delivery order is for the medical product Durolane 60mg/3ml, with a period of performance through October 30, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML medical supplies. The contract is a firm-fixed price delivery order with a ceiling value of $8,156.13 and an ultimate completion date of October 10, 2024. Amerisourcebergen, through its Corporate Office division, will supply these medical products to support various government agencies and healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,031.96, is a delivery order for the supply of 4562355218 DUROLANE 60 MG/3 ML SYRINGE 3ML. The contract has an ultimate completion date of October 2, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,072.25 firm fixed price delivery order is for the supply of 4566118162 DUROLANE 60 MG/3 ML SYRINGE 3ML, with a period of performance through October 17, 2024. The award is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,207.76 Firm Fixed Price delivery order is for 4566827509 - DUROLANE 60 MG/3 ML SYRINGE 3ML, with a performance period through January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The U.S. Department of Defense has awarded a $29,615.72 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with an ultimate completion date of October 7, 2024, is for the supply of DUROLANE 60MG/3ML 1S medical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the Defense Logistics Agency (DLA) Troop...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM4N2
    Delivery Order

This federal contract award, valued at $10,838.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a completion date of January 27, 2025. The contract is a Firm Fixed Price arrangement, with no set-aside designation.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 4/25/25, 9:43 AM